Background Despite the use of antiviral prophylaxis, cytomegalovirus (CMV) remains a
common opportunistic infection following heart transplantation. This study analyzes the …

Background Cytomegalovirus (CMV) infection remains a major complication after heart
transplantation with varying prophylaxis strategies employed. We sought to determine the …

Background The frequency and significance of cytomegalovirus (CMV) infection in
seropositive (R+) heart transplant recipients (HTR) is unclear, with preventative …

Background Cytomegalovirus (CMV) disease typically occurs during the first year after solid
organ transplantation, after cessation of antiviral prophylaxis. CMV occurring after the first …

Background Cytomegalovirus (CMV) infection remains a common complication after heart
transplantation (HTx). The association between CMV infection and allograft rejection is …

Background. Prior studies have shown that cytomegalovirus (CMV) infection is a risk factor
for the development of cardiac allograft vasculopathy (CAV) and is associated with reduced …

Purpose Cytomegalovirus (CMV) is regarded as one of the most significant opportunistic
pathogens in transplant recipients. We determined immunological risk factors to first CMV …

Purpose: Cytomegalovirus (CMV) diseases are frequent following heart transplant,
especially for patients with donor seropositive/recipient seronegative (D+/R-) CMV …

Background Few data support use of 6 over 3 months of antiviral prophylaxis for
cytomegalovirus (CMV) disease prevention in donor seropositive/recipient seronegative (D+ …

Background Some studies have shown that pre‐transplant cytomegalovirus (CMV)
serostatus is associated with heart transplant patient survival while others have not. We …